MINNEAPOLIS, Feb. 01, 2024 Panbela Therapeutics, Inc. , a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today.
Panbela Therapeutics (PBLA) Prices 4.375M Share Offering at $2.06/sh streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
MINNEAPOLIS, Jan. 29, 2024 (GLOBE NEWSWIRE) Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today
New Era Helium Corp. to List on NASDAQ Through Merger with Roth CH Acquisition V Co. streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
MIAMI, Dec. 29, 2023 Fortress Biotech, Inc. , an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic.